This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
Merck opens first climate-neutral manufacturing facility in Ireland
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Biocytogen will provide proprietary, fully human antibodies derived from its RenMice platform for evaluation in Merck’s antibody-conjugated LNP services
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
